Recent Quarter Total Invested
$391,000
-$126,000.00
Recent Quarter Institutional Ownership Percentage
1.12%
$0.00
Total Invested of Last Quarter
$517,000
Ownership Percentage of Last Quarter
1.11%
Kiora Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2022 | 547,128 | $257,000 | 3.28% | 0.73% |
| VANGUARD GROUP INC | 08/12/2022 | 67,212 | $31,000 | -12.72% | 0.09% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/15/2022 | 51,300 | $24,000 | 0.00% | 0.07% |
| CITADEL ADVISORS LLC | 08/15/2022 | 46,440 | $22,000 | 100.00% | 0.06% |
| RENAISSANCE TECHNOLOGIES LLC | 08/12/2022 | 41,835 | $20,000 | -55.31% | 0.06% |
| UBS GROUP AG | 08/10/2022 | 28,856 | $13,000 | 100.00% | 0.04% |
| BLACKROCK INC. | 08/12/2022 | 20,981 | $10,000 | 0.00% | 0.03% |
| CAPTRUST FINANCIAL ADVISORS | 08/23/2022 | 15,000 | $7,000 | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/15/2022 | 12,558 | $6,000 | 18.02% | 0.02% |
| US BANCORP \DE\ | 08/01/2022 | 2,710 | $1,000 | 0.00% | 0.00% |
| MORGAN STANLEY | 10/27/2022 | 333 | $0 | -4.58% | 0.00% |
| ALBION FINANCIAL GROUP /UT | 07/29/2022 | 254 | $0 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/12/2022 | 85 | $0 | 8.97% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 08/09/2022 | 0 | $0 | 0.00% | 0.00% |
| CITIGROUP INC | 08/10/2022 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2022 | 0 | $0 | -100.00% | 0.00% |
| ERGOTELES LLC | 08/12/2022 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/10/2022 | 0 | $0 | -100.00% | 0.00% |
Kiora Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
What percentage of Kiora Pharmaceuticals, Inc. stock is owned by institutional investors?
1.12% of Kiora Pharmaceuticals, Inc. stock is owned by institutional investors.